SRPT
Sarepta Therapeutics, Inc. · Healthcare
Director Hans Lennart Rudolf Wigzell sold $1.6M of Sarepta Therapeutics, Inc.
Sold$1,600,800
$106.72Price
15,000Shares
−42%Stake
What SRPT did after the filing
- The stock from Wed, Aug 9 open, $103.74
- +15.2%
- S&P 500, same days
- −3.6%
Measured over 30 trading days, to the Sep 21 close.
Traded Fri, Aug 4. Filed Tue, Aug 8, 4:00 PM ET, after the close. Returns use the Aug 9 open and the Sep 21 close. Not investment advice.